Biotech Values

[semi_infinite]

EYPT - Today was the opposite of yesterday. Started strong and ended up where we started before FDA clearance. Closed exactly at warrant exercise price. There must be ATM selling pressure anticipated. Not sure how much Yutiq is worth even though it is 1st line therapy. If they get 100% of the market, it would be around $8K X 30K cases/year. $8K is from Iluvien DME pricing (licensed to Alimera).